Bajaj HealthCare Limited (NSE:BAJAJHCARE)
468.35
-18.20 (-3.74%)
Aug 1, 2025, 3:30 PM IST
Bajaj HealthCare Revenue
Bajaj HealthCare had revenue of 1.49B INR in the quarter ending June 30, 2025, with 12.54% growth. This brings the company's revenue in the last twelve months to 5.59B, up 17.50% year-over-year. In the fiscal year ending March 31, 2025, Bajaj HealthCare had annual revenue of 5.43B with 14.61% growth.
Revenue (ttm)
5.59B
Revenue Growth
+17.50%
P/S Ratio
2.75
Revenue / Employee
5.33M
Employees
1,049
Market Cap
15.38B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 5.43B | 691.85M | 14.61% |
Mar 31, 2024 | 4.73B | -1.72B | -26.69% |
Mar 31, 2023 | 6.46B | -340.94M | -5.01% |
Mar 31, 2022 | 6.80B | 229.06M | 3.49% |
Mar 31, 2021 | 6.57B | 2.46B | 59.96% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 537.09B |
Divi's Laboratories | 93.60B |
Cipla | 274.80B |
Apollo Hospitals Enterprise | 217.94B |
Mankind Pharma | 128.90B |
Zydus Lifesciences | 232.42B |
Aurobindo Pharma | 317.24B |
Fortis Healthcare | 77.86B |
Bajaj HealthCare News
- 4 months ago - Bajaj Healthcare shares rise nearly 3% as company acquires GenRx Pharmaceuticals to strengthen manufacturing footprint - Business Upturn
- 6 months ago - Bajaj Healthcare shares rise 5% in weak market as Q3 revenue jumps 13% YoY - Business Upturn
- 6 months ago - Corporate Earnings to Watch on February 11: Lupin, Vodafone Idea, Berger Paints, IRCTC, SAIL, and More - Business Upturn
- 6 months ago - Bajaj Healthcare secures DCGI approval to manufacture Pimavanserin in India - Business Upturn
- 7 months ago - Bajaj Healthcare shares surge 12% after securing exclusive rights for Magtein® in India - Business Upturn
- 7 months ago - Bajaj Healthcare secures exclusive rights for Magtein® in India from Threotech LLC - Business Upturn
- 8 months ago - Bajaj Healthcare shares surge 2% on new CDMO agreement with UK/EU clients - Business Upturn
- 8 months ago - Bajaj Healthcare signs CDMO contract for 15 new APIs with UK/EU companies - Business Upturn